ReviewLe infezioni in medicina2024
Cholera resurgence in Africa: assessing progress, challenges, and public health response towards the 2030 global elimination target.
Review in Le infezioni in medicina, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Molecular characterization ofIJID regions · 2026Article
- Beyond access: WASH, public health, and sustainable development priorities in Africa-a narrative review.Tropical medicine and health · 2026Review
- Determinants of recovery time from cholera in a conflict-affected agro-pastoral region of ethiopia: evidence from survival models.Conflict and health · 2026Article
- Health and economic burdens of emerging infectious diseases in the USA, US territories and globally.BMJ global health · 2026Article
- Decentralised rapid diagnostic tests enable cholera diagnosis by non-laboratory health workers during outbreaks in Cameroon.Scientific reports · 2026Article
- Environmental surveillance of pathogens in Africa.Applied and environmental microbiology · 2026Review
- Cholera in Africa: Current trends, challenges, and control towards elimination strategies.PLoS neglected tropical diseases · 2026Review
- Oral cholera vaccine uptake, acceptance and confidence among residents of a high-risk township in Zambia: key insights for future vaccination programs.International health · 2026Article
- Strengthening disaster preparedness and health security in Niger state, Nigeria through a WHO STAR-based multi-hazard risk assessment.Scientific reports · 2026Article
- Recent epidemiological and management approaches for cholera in India.Proceedings (Baylor University. Medical Center) · 2026Review
- Addressing the Recurrent and Protracted Cholera Outbreaks in Africa: Challenges and the Way Forward.Nature communications · 2025Article
- Descriptive study of cholera-related deaths in communities during Zambia's 2023-2024 outbreak: key insights.BMJ open · 2025Article
- Geographical shifting of cholera burden in Africa and its implications for disease control.Nature medicine · 2025Article
- Cholera in Nigeria: a five-decade review of outbreak dynamics and health system responses.Journal of health, population, and nutrition · 2025Review
- Coupling plankton and cholera dynamics: Insights into outbreak prediction and practical disease management.PLoS computational biology · 2025Article
- Intra action review of the cholera outbreak response in Kadoma city, Zimbabwe, 2024.BMC public health · 2025Article
- Cholera resurges in Zambia: Challenges and future directions.IJID regions · 2025Review
- Allocation of Oral Cholera Vaccines in Africa.Vaccines · 2025Article
- Exploring the Impact of Traditional Practices onInternational journal of environmental research and public health · 2025Article
- Cholera Outbreak in Nigeria: History, Review of Socioeconomic and Meteorological Drivers, Diagnostic Challenges, and Artificial Intelligence Integration.Global health, epidemiology and genomics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Global efforts to combat epidemic cholera outbreaks have witnessed tremendous feats over the decades. However, sporadic outbreaks in regions, particularly across African states, mask these advancements. This regressive trend is frequently fuelled by factors retarding efforts towards optimal environmental sanitation and personal hygiene, which include ingesting infected food, drinking contaminated waters, and engaging in unhealthy environmental practices such as indiscriminate waste and sewage disposal and poor toilet practices. The ongoing efforts to achieve the Global Taskforce on Cholera Control (GTFCC) targets of a 90% reduction in cases and deaths by 2030, even in the wake of continuous outbreaks across various African regions, as reported by the World Health Organization (WHO) face a significant threat. One such effort, among others, is the AFRICHOL project, an enhanced cholera surveillance consortium launched in Africa over a decade ago as part of the GTFCC at WHO to monitor and fast-track the GTFCC's 2030 targets. It is tasked with supporting the implementation of research-based strategies for combating cholera in Africa. The prequalified oral cholera vaccines - Dukoral, Shanchol, and Euvichol - and those with recombinant DNA technology have also emerged as remarkable strides. In the face of this progress, challenges persist. Climate change, including extreme weather events and the lack of safe water, sanitation, and hygiene facilities, acts as a multiplier, amplifying existing challenges and hindering progress. Porous borders with inefficient disease surveillance networks among member states also facilitate the inter-territorial spread of the disease. Despite ongoing challenges, global targets are achievable provided strong institutional infrastructure and additional evidence-based public health initiatives are promulgated and enacted. The Global Roadmap to Ending Cholera Outbreaks by 2030 is a resourceful tool for advancing this fight and eradicating cholera.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.